Sarepta, continuing its gene therapy push, helps launch a startup
Bio Pharma Dive
OCTOBER 22, 2020
The biotech has joined a group of investors to form a new gene therapy developer led by one of its longtime executives and backed with $107 million.
Sat.Oct 17, 2020 - Fri.Oct 23, 2020
352 
10 Trends for online health seekers
World of DTC Marketing
OCTOBER 21, 2020
IN SUMMARY: Online health seekers are using the Internet differently since the pandemic. Treatment options are researched more, and people are using, but not relying, on social media to gather information on what’s best for THEM. I’ve spent the last three months gathering information on how online health seekers are using the Internet. My research points were Google, Twitter, and various websites that provide metrics on a variety of topics.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Using Behavioral Science in A Digital World
Pharma Mirror
OCTOBER 22, 2020
By Rotem Shor, Medisafe Chief Technology Officer Technology and health have experienced a convergence in the last few years, leading to a new state of digital health that is transforming how we live and work. But there is a greater science behind it that analyzes tremendous amounts of data to shape and personalize our health. The post Using Behavioral Science in A Digital World appeared first on Pharma Mirror Magazine.
Johns Hopkins Scientists Discover Possible Key to Controlling COVID-19 Immune Response
BioSpace
OCTOBER 18, 2020
They believe that by inhibiting factor D, it would reduce the inflammatory reactions that make COVID-19 so deadly.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Biogen is running out of safety nets
Bio Pharma Dive
OCTOBER 21, 2020
Third quarter earnings underscore just how vital it is that Biogen secure approval of its experimental Alzheimer's drug, given the challenges elsewhere in its business.
Pharma still doesn’t understand transparency
World of DTC Marketing
OCTOBER 20, 2020
As development towards a COVID-19 vaccine continue so do the number of people who have said they won’t get vaccinated. The only way to get people on board with a vaccination is complete transparency about the product yet both J&J and Pfizer remain silent. Pausing clinical trials for any drug is normal when a participant gets sick. There has to be a complete investigation as to why the patient suffered ill effects including the possibility that he/she had a known or unknown health condi
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Novartis launches digital health hub in Canada
pharmaphorum
OCTOBER 23, 2020
Novartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for patients and healthcare providers. The Canadian Biome Digital Innovation Hub will be based in Montreal at the artificial intelligence research institute, Mila. The institute formed a strategic alliance with Novartis in 2019. Canada is the latest country to join a global network of hubs opened by Novartis.
Roche joins the COVID-19 antiviral drug race, betting $350M on a startup
Bio Pharma Dive
OCTOBER 22, 2020
A deal with Atea Pharmaceuticals gives Roche rights to an oral antiviral for coronavirus disease that would compete with emerging therapies from Pfizer and Merck.
Pharma managers too far removed from patients
World of DTC Marketing
OCTOBER 22, 2020
As people move up the pharma ladder, their work often revolves around internal management issues, training, and endless meetings to motivate their employees rather than focus on patients. Pharma likes to believe its own propaganda that everything they do is patient-focused, but that’s a canard. Pharma’s own internal processes and endless meetings are slowly draining the life out of employees and lead to a culture where people are promoted to navigate the system rather than help peopl
New research highlights Northern Ireland’s ‘thriving’ life sciences sector
Pharma Times
OCTOBER 21, 2020
Pharmaceutical and life sciences industries are growing in importance across country
UK trials digital ‘health passport’ to help borders reopen
pharmaphorum
OCTOBER 19, 2020
Regular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could be added to pre-flight checks backed by a digital “health passport” to prove passengers are free from the coronavirus. The UK is the latest country to test the scheme that allows passengers to demonstrate their coronavirus status as part of a global framework for COVID-safe air travel.
CRISPR Therapeutics reports remissions, one death in cancer cell therapy study
Bio Pharma Dive
OCTOBER 21, 2020
The biotech is one of several attempting to develop "off-the-shelf "CAR-T therapies. While trial results show potential, high-dose treatment was paused following a patient's death.
Projections on pharma digital ad spending wrong
World of DTC Marketing
OCTOBER 19, 2020
GOOD MORNING: eMarketer is promoting a report on pharma’s projected digital ad spending in the coming year, and from my conversations with pharma insiders, it’s wrong. There will be an investment in new digital platforms but display and search spending, I believe, are going to decline. There is no doubt that more people are turning to the Internet to help sort through the conflicting health information but that does not translate into more online ads.
IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s Risk
BioSpace
OCTOBER 22, 2020
Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample. They published the research today in The Lancet eClinicalMedicine.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Toxic positivity and grief: The reality of living through cancer
pharmaphorum
OCTOBER 22, 2020
Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through cancer unscathed. People are usually left with a mixture of treatment aftereffects, toxic positivity, and lingering anger to deal with. Megan-Claire Chase , a fierce patient advocate who has been blogging about her experiences since she was diagnosed with breast cancer in 2015, said the disease never went away.
Gilead's Veklury becomes first FDA-approved drug for COVID-19
Bio Pharma Dive
OCTOBER 22, 2020
The U.S. regulator granted a full approval after allowing emergency use earlier this year. New results from an WHO study, however, raise questions about the drug's ultimate effectiveness.
What cold lizards in Miami can tell us about climate change resilience
Scienmag
OCTOBER 21, 2020
Credit: Photo courtesy Day’s Edge Productions It was raining iguanas on a sunny morning. Biologist James Stroud’s phone started buzzing early on Jan. 22. A friend who was bicycling to work past the white sands and palm tree edges of Key Biscayne, an island town south of Miami, sent Stroud a picture of a 2-foot […].
COVID-19 biologics will put huge pressure on large-scale bioprocessing networks
Pharma Mirror
OCTOBER 20, 2020
Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity Amsterdam: The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) – predicts, that if approved, COVID vaccines and therapeutics will cause an impending biomanufacturing capacity.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’
Pharma Times
OCTOBER 19, 2020
Chief executive of trade body warns no-deal could affect medicines supply
Intellia cleared to start key CRISPR drug study in UK
Bio Pharma Dive
OCTOBER 19, 2020
The trial would be the first test of a systemically administered gene editing treatment that uses the Nobel Prize-winning technology to alter DNA.
How real human experiences can power a healthier future
pharmaphorum
OCTOBER 19, 2020
As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be 100 will be the norm. While this seems like a desirable aspiration for our grandchildren, it adds new pressures on our healthcare systems.
CPhI Worldwide to return in 2021: Milan venue to play host to global pharma
Pharma Mirror
OCTOBER 20, 2020
2021 will bring global pharma community back together in person to drive business growth CPhI Worldwide (31 August – 2 September 2021) will be held next year in Milan (Fiera Milano) for the first time in over a decade – following its postponement in 2020. The event returns at an apt moment, as the pharma industry in. The post CPhI Worldwide to return in 2021: Milan venue to play host to global pharma appeared first on Pharma Mirror Magazine.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Neural Dust: Millimeter-Sized Brain Stimulators
BioSpace
OCTOBER 22, 2020
Bolstered by studies in rodents, iota Biosciences advances towards their vision.
Facing vaccine doubts, US grapples with building confidence in coronavirus shots
Bio Pharma Dive
OCTOBER 22, 2020
The CDC, for example, doesn't support vaccine mandates for healthcare workers or essential employees, an agency official told experts convened by the FDA Thursday.
Kite cues up first EMA okay for mantle cell lymphoma CAR-T
pharmaphorum
OCTOBER 19, 2020
Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its Tecartus therapy for mantle cell lymphoma. The EMA’s human drugs advisory committee recommended approval of Tecartus (brexucabtagene autoleucel; formerly KTE-X19 ) for relapsed or refractory MCL setting up a formal approval by the regulator in the coming weeks.
WHO: remdesivir shows little effect on COVID-19
Outsourcing Pharma
OCTOBER 19, 2020
The agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.
Vanquishing COVID-19 by Decreasing Viral Inoculum
BioSpace
OCTOBER 18, 2020
Dr. Monica Gandhi, MD, an infectious diseases doctor and professor of medicine at UC San Francisco, poses the hypothesis that masks and other social distancing measures may reduce the viral inoculum – or amount – of the SARS-CoV-2 we contract.
Ex-Medivation team nets $500M to take their new cancer drugmaker to Wall Street
Bio Pharma Dive
OCTOBER 21, 2020
Nuvation Bio, a large oncology startup run by former Medivation executives, is capitalizing on a boom in mergers with so-called special purpose acquisition company, or SPACs.
Fats fighting back against bacteria
Scienmag
OCTOBER 19, 2020
Droplets of fat inside our cells are helping the body’s own defence system fight back against infection, University of Queensland researchers have discovered. Credit: Institute for Molecular Bioscience, University of Queensland Droplets of fat inside our cells are helping the body’s own defence system fight back against infection, University of Queensland researchers have discovered.
Time to change the channel? The future for customer engagement models
pharmaphorum
OCTOBER 20, 2020
Sarah Rickwood delves into IQVIA data to find out exactly how pharma’s HCP engagement has changed over COVID-19, and what the channel mix might look like after the pandemic. The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. With in-person visits drastically reduced, pharma has been challenged to find ways to continue engaging effectively with HCPs via remote channels.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content